Most recently, Expedition Therapeutics raised $115.0M in its Series B (Aug 2026).
- ·The post-money valuation on its round
- ·The complete investor list: 14 names
- ·Watch Expedition Therapeutics: the Monday email on marks, rounds and moves
Expedition Therapeutics round by round
1 roundsHow much has Expedition Therapeutics raised?
Expedition Therapeutics has raised $165 million in total; 1 of its rounds is on record. The largest on record was an $115 million Series B in Aug 2026. 1 of the rounds disclosed a post-money valuation.
Expedition Therapeutics investors
14 investors are on record for Expedition Therapeutics, including General Atlantic, RA Capital Management, Novo Holdings and Venrock. By type, the record holds 4 hedge funds, 3 venture capital firms and 1 asset manager. 1 of them led a round. The Series B in Aug 2026 drew 13 investors.
14 investors have backed Expedition Therapeutics.
Frequently asked about Expedition Therapeutics
- How much has Expedition Therapeutics raised?
- Expedition Therapeutics has raised $165.0M in total across 1 recorded funding rounds.
- Who are Expedition Therapeutics's lead investors?
- Lead investors in Expedition Therapeutics's recorded rounds include General Atlantic.
- When was Expedition Therapeutics's last funding round?
- Expedition Therapeutics's most recent recorded round was Series B in Aug 2026, raising $115.0M.